List of vaccines and treatments for COVID-19

All applications for vaccines and treatments for COVID-19 received by Health Canada.

Product name Company name Product type Status Date of approval Approved for different indication ID
Janssen COVID-19 Vaccine (Ad26.COV2.S [recombinant]) Janssen Inc Vaccine Authorized By Interim Order No 27
AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant]) AstraZeneca Canada Inc Vaccine Authorized By Interim Order No 28
COVISHIELD (ChAdOx1-S [recombinant]) Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order No 29
COVID-19 Vaccine Moderna (mRNA-1273 SARS-CoV-2) ModernaTX, Inc. Vaccine Authorized By Interim Order No 15
Pfizer-BioNTech COVID-19 Vaccine (tozinameran) BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order No 16
Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order No 8
Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized No 9
Favipiravir (favipiravir) Dr Reddys Laboratories Ltd Treatment Under review Under review 17
Colchicine (colchicine) Pendopharm Division of Pharmascience Inc Treatment Under review Under review Yes 18
Novavax COVID-19 Vaccine (NVX-CoV2373) Novavax Inc Vaccine Under review Under review No 31
Bamlanivimab and etesevimab (LY-CoV555 / LY-CoV016) Eli Lilly Canada Inc Treatment Under review Under review No 32
Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Under review Under review No 34
Leronlimab (leronlimab) CytoDyn, Inc. Treatment Under review Under review No 35
Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Under review Under review No 36
Coronavirus-like Particle (CoVLP) COVID-19 Vaccine (coronavirus-like particle [CoVLP]) Medicago Inc Vaccine Under review Under review No 38
Olumiant (baricitinib) Eli Lilly Canada Inc Treatment Under review Under review Yes 39